Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.44 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.43 |
| ▸ | FEN1 | P39748 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5087955 | 0.86 | NPC1 (0.51) | MEN1KMT2AALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL4865622 | 0.84 | AKR1C3 (0.58) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL11774603 | 0.81 | ALDH1A1 (0.56) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL1073512 | 0.81 | MAPT (0.55) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL11775173 | 0.81 | ALDH1A1 (0.56) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL778665 | 0.78 | KDM4E (0.48) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL38659501 | 0.78 | MCL1 (0.57) | KDM4EMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL7200630 | 0.77 | NPC1 (0.53) | KDM4EMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL29425530 | 0.77 | HPGD (0.54) | KDM4EALDH1A1SMN1; SMN2TSHRHPGD | |
| SCHEMBL166603 | 0.77 | HPGD (0.54) | KDM4EALDH1A1SMN1; SMN2TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108883041-B | Personal care compositions comprising hair repair blends | ELC 管理有限责任公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3407858-B1 | A METHOD FOR TREATING THE APPEARANCE OF THINNING HAIR | ELC MAN LLC (US) | 2021-10-13 | — | — | EP | claimed |
| EP-3407857-B1 | PERSONAL CARE COMPOSITION COMPRISING A HAIR RESTORATIVE BLEND | ELC MAN LLC (US) | 2020-10-28 | — | — | EP | claimed |
| US-20200268770-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | MONKAM NITCHEU GUY FAUSTIN (FR) | 2020-08-27 | — | — | US | claimed |
| EP-3565536-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | Monkam Nitcheu, Guy Faustin (FR) | 2019-11-13 | — | — | EP | claimed |
| US-10292997-B2 | Compositions and methods for stimulating wound healing | Rastein, Daniel N. (US) | 2019-05-21 | — | — | US | claimed |
| WO-2018127748-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | MONKAM NITCHEU GUY FAUSTIN (FR) | 2018-07-12 | — | — | WO | claimed |
| CN-107115414-A | Nutriment for preventing and treating diabetes B is combined | 刘新丰 | 2017-09-01 | — | — | CN | claimed |
| EP-1755401-B1 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO ENHANCE CREATINE TRANSPORT | IN INGREDIENTS INC (US) | 2016-11-23 | — | — | EP | claimed |
| EP-3038474-A1 | NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES | Liu, Charles H. (US) | 2016-07-06 | — | — | EP | claimed |
| EP-1755401-A1 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO ENHANCE CREATINE TRANSPORT | MILLER, Peter (US) | 2007-02-28 | — | — | EP | claimed |
| WO-2006079056-A1 | HERBAL COMPOSITIONS CONTAINING HOODIA | HOLT STEPHEN (US) | 2006-07-27 | — | — | WO | claimed |
| US-20060159773-A1 | Herbal compositions containing hoodia | HOLT STEPHEN | 2006-07-20 | — | — | US | claimed |
| WO-2006020091-A2 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO PROMOTE WEIGHT LOSS | INTEGRITY NUTRACEUTICALS INTERNATIONAL (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060013361-A1 | Method for measurement of the three-dimensional density distribution in bones | Siemens Healthineers Ag (DE) | 2006-01-19 | — | — | US | claimed |
| US-20060013903-A1 | Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss | IN INGREDIENTS, INC. | 2006-01-19 | — | — | US | claimed |
| US-6967030-B2 | Formulation for insulin and glucose control | WRIGHT JONATHAN V | 2005-11-22 | — | — | US | claimed |
| WO-2005099455-A1 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO ENHANCE CREATINE TRANSPORT | MILLER PETER (US) | 2005-10-27 | — | — | WO | claimed |
| US-20040224035-A1 | Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport | IN INGREDIENTS, INC. | 2004-11-11 | — | — | US | claimed |
| US-20040137090-A1 | Formulation for insulin and glucose control | WRIGHT JONATHAN V (US) | 2004-07-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060159773-A1 | Herbal compositions containing hoodia | CBX2, CBX7, CYP46A1 | KDM4E 2105/4885MEN1 2051/4885KMT2A 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.